TIGREAT 2.5 mg, film-coated tablet 12 tablets
Active ingredients: Frovatriptan, Frovatriptan succinate hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TIGREAT 2,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 12 comprimé(s)
- Marketing authorisation holder
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60435263CIP73023113CIP133400930231135Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FROVATRIPTAN BASEcomprimé | 2,50 mg · un comprimé | FT |
| SUCCINATE DE FROVATRIPTAN MONOHYDRATÉcomprimé | 3,91 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.